VANCOMYCIN PHARMACOKINETICS IN NORMAL AND MORBIDLY OBESE SUBJECTS

被引:201
作者
BLOUIN, RA
BAUER, LA
MILLER, DD
RECORD, KE
GRIFFEN, WO
机构
[1] UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,COLL MED,DEPT SURG,LEXINGTON,KY 40536
[2] UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,COLL PHARM,LEXINGTON,KY 40536
[3] UNIV WASHINGTON,SCH PHARM,SEATTLE,WA 98195
关键词
D O I
10.1128/AAC.21.4.575
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:575 / 580
页数:6
相关论文
共 19 条
[1]  
ALEXANDER J K, 1962, Cardiovasc Res Cent Bull, V1, P39
[2]   AMIKACIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BAUER, LA ;
BLOUIN, RA ;
GRIFFEN, WO ;
RECORD, KE ;
BELL, RM .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1980, 37 (04) :519-522
[3]  
BERMAN M, 1968, USERS MANUAL SAAM
[4]   TOBRAMYCIN PHARMACOKINETICS IN MORBIDLY OBESE PATIENTS [J].
BLOUIN, RA ;
MANN, HJ ;
GRIFFEN, WO ;
BAUER, LA ;
RECORD, KE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1979, 26 (04) :508-512
[5]   THEOPHYLLINE CLEARANCE - EFFECT OF MARKED OBESITY [J].
BLOUIN, RA ;
ELGERT, JF ;
BAUER, LA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (05) :619-623
[6]   GENTAMICIN THERAPY [J].
DEVINE, BJ .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1974, 8 (11) :650-655
[7]   ESTIMATING CREATININE CLEARANCE IN MORBIDLY OBESE PATIENTS [J].
DIONNE, RE ;
BAUER, LA ;
GIBSON, GA ;
GRIFFEN, WO ;
BLOUIN, RA .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1981, 38 (06) :841-844
[8]  
DuBois D, 1915, ARCH INTERN MED, V15, P868
[9]  
GAL P, 1978, CLIN PHARMACOL THER, V23, P438
[10]  
GERACI JE, 1977, MAYO CLIN PROC, V52, P631